Sandbox Myopathy: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
Line 99: | Line 99: | ||
|- | |- | ||
|Spinal muscle atrophy | |Spinal muscle atrophy | ||
| | |||
| | |||
| | |||
|- | |||
|Fibomyalgia | |||
| | |||
| | |||
| | |||
|- | |||
|Polymyalgia Rheumatica | |||
| | | | ||
| | | | ||
Line 186: | Line 196: | ||
| | | | ||
|- | |- | ||
! colspan="4" |Metabolic | |||
|- | |||
|Glycogen storage disease | |||
| | |||
| | |||
| | |||
|- | |||
|Lipid storage disease | |||
| | |||
| | |||
| | | | ||
|- | |||
|Mitochondrial | |||
| | | | ||
| | | | ||
| | | | ||
|} | |} |
Revision as of 16:11, 21 March 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Differentiating Various Muscle Weakness
Medications | |||
---|---|---|---|
Corticosteroids | |||
Statins | |||
Anti-Thyroid | |||
Chemotherapeutic | |||
Organophosphate intoxication | |||
Alcohol | |||
Endocrine | |||
Adrenal insufficiency | |||
Cushing's disease | |||
Secondary hyperparathyroidism | |||
Hyperthyroidism | |||
Hypothyroidism | |||
Inlammatory | |||
Dermatomyositis | |||
Polymyositis | |||
Inclusion body myositis | |||
Rheumatologic | |||
Cervical spondylosis | |||
Degenerative disc disease | |||
Spinal cord injury | |||
Spinal muscle atrophy | |||
Fibomyalgia | |||
Polymyalgia Rheumatica | |||
Genetic | |||
Becker muscular dystrophy | |||
Limb-girdle muscular dystrophies | |||
Myotonic dystrophy type 1 | |||
Infectious | |||
Lyme disease | |||
Infulenza | |||
Polio | |||
Syphilis | |||
HIV | |||
Neurologic | |||
ALS | |||
Stroke | |||
GBS | |||
Multiple Sclerosis | |||
Neuro-muscular | |||
Botulisim | |||
Lambert-Eaton myaes | |||
Myasthenia gravis | |||
Metabolic | |||
Glycogen storage disease | |||
Lipid storage disease | |||
Mitochondrial |